BWX Technologies, Inc. (BWXT) Up 5.0% — Should I Act on This Strength?
BWX Technologies, Inc. (BWXT) is pushing higher on Friday, currently changing hands at $127.51 on the NYSE — a $6.01 gain from the prior close of $121.50. The bounce gives investors a welcome reprieve in a name that has been deeply discounted. Even after today's advance, BWXT trades roughly 47.3% below its 52-week high of $241.82, a level reached on April 16, 2026. That gap leaves substantial room for recovery if sentiment toward nuclear names continues to firm.
Volume is tracking close to normal, with approximately 1.11 million shares traded against a 90-day average of roughly 1.08 million. Turnover has already edged past the typical full-session level while the regular session remains open.
Why BWX Technologies, Inc. Price is Moving Higher
Today's advance is best read as part of a sector-wide relief rally across nuclear power stocks. Bargain hunters returned in force to a group that had been hit hard in recent weeks. Oklo (OKLO) jumped roughly 18% in morning trading, NuScale (SMR) gained about 12%, and NANO Nuclear (NNE) climbed around 11% as investors stepped back into beaten-down nuclear names. BWXT, sitting nearly half off its April peak, was a natural beneficiary of that rotation. The broader tape helped too. A stronger-than-expected jobs report showing 165,000 jobs added and a 4.1% unemployment rate supported risk appetite across the market, and industrial names with growth exposure caught a bid alongside it. Within the broader Industrials sector, Vertiv Holdings Co (VRT) gained 3.30% and Deere & Company (DE) rose 1.76%.
What makes BWXT especially compelling in this rebound is that the fundamentals underneath it are firming. On November 2, the company reported Q3 adjusted EPS of $1.26, ahead of the $1.19 consensus and up 26% year over year. Revenue rose 10% to $953.0 million, short of the $973.1 million estimate but still a solid double-digit pace. Profitability was the bright spot. Net income climbed 24% to $102.0 million, and adjusted EBITDA increased 19% to $179.7 million, which shows the company is converting top-line growth into earnings at an accelerating rate.
Management's guidance reinforces the opportunity. BWXT tightened its 2026 adjusted EPS outlook to $4.72–$4.77 and its free cash flow outlook to $350 million–$360 million. It also forecast high-single-digit revenue growth for 2027, giving investors visibility well beyond the current year. The same day, BWXT announced that its reactor technology had been selected for the Army's Janus project at Fort Campbell. That milestone strengthens the company's position in defense microreactors and adds a constructive backdrop to today's sector-driven bounce.
What is the BWX Technologies, Inc. Rating - Should I Buy?
Weiss Ratings assigns BWXT a C+ rating. Current recommendation is Hold. The rating sits at the upper edge of the Hold range. It captures a business with first-rate operating fundamentals whose stock has been through a punishing stretch. For investors, that combination is exactly where opportunity tends to surface.
The fundamental case is about as strong as it gets. BWXT is rated Excellent on the Growth Index, the Efficiency Index, and the Solvency Index. The Growth Index rating reflects 10.01% revenue growth paired with a 26% jump in third-quarter adjusted EPS. Earnings are outpacing sales, which signals that the company's long-cycle government and commercial contracts are scaling profitably. Return on equity of 28.27% supports the Excellent Efficiency Index rating. That is a standout figure for a capital goods manufacturer building highly specialized nuclear components under strict regulatory oversight. A 10.40% profit margin shows BWXT is not sacrificing returns to win that work. The Excellent Solvency Index rating suggests the balance sheet can fund reactor development, fuel programs, and expansion without strain. Guidance for $350–$360 million in free cash flow this year backs up that view.
Where the picture becomes more nuanced is in the market-facing dimensions. The Total Return Index is rated Fair, a reasonable reading for a stock that has given back nearly half its value since April. The Weak Volatility Index reflects that same drawdown. Today's nearly 5% swing, driven by a sector-wide surge in nuclear names, shows how sharply BWXT moves with sentiment toward the group. The Dividend Index is also rated Weak, because a 0.87% yield makes BWXT a growth-and-recovery story rather than an income holding. With a forward P/E of 29.79, the valuation already assumes continued execution. These market-facing ratings are what keep the overall grade at C+ rather than in Buy territory.
Within the Industrials sector, BWXT sits alongside Deere & Company (DE, C+), Vertiv Holdings Co (VRT, C+), and Northrop Grumman Corporation (NOC, C+). It ranks ahead of TransDigm Group Incorporated (TDG, C). Few names in that group, however, pair Excellent ratings across growth, efficiency, and solvency with a share price this far below its recent peak.
About BWX Technologies, Inc.
BWX Technologies, Inc. (BWXT) is an Industrials company that specializes in nuclear components, fuel, and services for government and commercial customers. Headquartered in Lynchburg, Virginia, the company's core franchise is supplying naval nuclear reactors and components for the U.S. Navy's submarines and aircraft carriers. BWXT has filled that role for decades, and few companies have the security clearances, facilities, or engineering depth to replicate it. Its Government Operations segment also manufactures nuclear fuel and handles uranium processing and down-blending for the U.S. government. It manages and operates sensitive government nuclear sites as well.
The Commercial Operations segment extends that expertise into civilian markets. BWXT designs and manufactures steam generators, reactor components, and fuel handling equipment for commercial nuclear power plants, with a significant presence in Canada's CANDU reactor fleet. Through BWXT Medical, the company produces medical radioisotopes and radiopharmaceuticals used in diagnostic imaging and cancer treatment.
The company's competitive advantages rest on sole-source positions in naval propulsion, long-duration government contracts, and a growing role in advanced nuclear technology. BWXT is developing microreactor designs for defense and remote-power applications, including work under the Department of Defense's Project Pele. Its newly announced selection for the Army's Janus project at Fort Campbell builds on that effort. The company also produces TRISO fuel for advanced reactors. These capabilities position BWXT to capture demand from naval shipbuilding and from the broader buildout of next-generation nuclear power.
Investor Outlook
BWX Technologies, Inc. (BWXT) carries a Weiss Rating of C+ (Hold). Excellent fundamentals, raised visibility into 2027, and a share price still 47.3% below its 52-week high make it a name worth close attention as nuclear sentiment recovers. Investors should watch whether the sector rebound holds and whether BWXT delivers on its adjusted EPS and free cash flow targets for 2026. Progress on microreactor programs such as Janus will also be a key signal. See full rankings of all C+ rated Industrials stocks inside the Weiss Stock Screener.
--